"[AstraZeneca executive Mark Esser] said on February 4 [2020], 'We got a call from DARPA telling us that COVID had been declared a national security threat.'" Sasha Latypova, a retired pharmaceutical research and development executive, describes for Sarah Westall how DARPA - particularly Colonel Matthew Hepburn - coordinated the COVID injection campaign in the United States.
Latypova, pointing to a six-minute recording of AstraZeneca executives talking about how they followed DARPA's lead, notes that the US Department of Defense agency responsible for the COVID injection was responsible for the pandemic. DOD agency, which is responsible for developing new technologies for the military, assembled a "consortium" of pharmaceutical companies including AstraZeneca in 2017 with the stated goal of developing "drugs and vaccines" within 60 days of receiving the "code" (i.e., the alleged genetic sequence) for a novel pathogen.
"I can tell you the exact date they started this operation," says Latypova. "By 'they' I mean the person who gave the trigger on the Defense Department side; his name is Colonel Matthew Hepburn. He was at DARPA [Defense Advanced Research Projects Agency] at the time." "So he [Hepburn] was at DARPA at the time. He made the call," notes Latypova. "I'm not saying he's the mastermind behind all this. [Although] he claims that he developed the pandemic preparedness plan in public presentations. But he was the one who made the call on February 4, 2020 with a pharmaceutical consortium [founded to produce 'pan-influenza vaccines']"
"So [this] consortium of pandemic preparedness... pharmaceutical companies and all kinds of medical device companies, [which] numbered in the hundreds... was supposedly working on what they called 'pan-influenza vaccines,' and this started at least in 2017, maybe earlier... And I have an audio recording... [of] two senior executives talking about this. One is [AstraZeneca] CEO Pascal Soriot and the other is [AstraZeneca] vice president of monoclonal antibodies Mark Esser. And they're discussing in a board meeting how the whole thing has evolved since 2017, when DARPA approached them to be part of this consortium."
The retired pharmaceutical R&D executive adds: "What's interesting is that Mark Esser said at the time, 'I thought this was science fiction.' Now, since Mark Esser is an experienced drug developer, he knows that this is science fiction that he's being asked to do. [Develop drugs/'vaccines' for a novel pathogen within 60 days] So that was his first reaction. But then he kind of said, 'Oh, no... then I realized that this is actually possible. It is possible to develop these completely novel... mRNA or adenoviruses or whatever ['vaccines'], [and] the monoclonal antibodies within, you know, 60 days or even sooner."
Latypova continues: "Then, further into this recording...they say, 'Oh, yeah. And...then we realized that all this was great, because, of course, the money from the Department of Defense is very good and convincing.' And then they started working on it for a while, for several years. That was great. You know, the Department of Defense gives them grants, with no specific results. They get to play science. And then, you know, on February 4 [2020], he said, 'We got a call from DARPA telling us that COVID was declared a national security threat. And this is, I remind you, a whole month before a pandemic was announced. And, you know, Trump signed the Stafford Act declaration for all 50 states and for some reason put FEMA in charge...[as] the lead agency. But here we have DARPA calling [the] pharmaceutical consortium and telling them it's a national security threat. Switch your pan-influenza [manufacturing] to COVID."